ArticleJournal of ovarian research2017

Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.

Benoît Thibault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.